540359 PARMAX

Parmax Pharma Share Price

 

 

Start SIP in PARMAX

Start SIP
Parmax Pharma live price: ₹27.8. It opened at ₹28 vs previous close ₹27; intraday high/low: ₹28/₹28. The 50 & 200 DMA stand at ₹32.31/₹34.92.

Parmax Pharma Performance

  • Low
  • ₹28
  • High
  • ₹28
  • 52 Week Low
  • ₹25
  • 52 Week High
  • ₹55
  • Open Price₹28
  • Previous Close₹27
  • Volume4
  • 50 DMA₹32.31
  • 100 DMA₹33.24
  • 200 DMA₹34.92

Investment Returns

  • Over 1 Month -12.99%
  • Over 3 Month -17.36%
  • Over 6 Month -18.59%
  • Over 1 Year -33.4%

Smart Investing Starts Here Start SIP with Parmax Pharma for Steady Growth!

Invest Now

Parmax Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -2.1
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 10
  • P/B Ratio
  • -1.7
  • Average True Range
  • 2.85
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.76
  • RSI
  • 37.19
  • MFI
  • 48.07

Parmax Pharma Financials

Parmax Pharma Technicals

EMA & SMA

Current Price
₹27.80
+ 0.37 (1.35%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹31.12
  • 50 Day
  • ₹32.31
  • 100 Day
  • ₹33.24
  • 200 Day
  • ₹34.92

Resistance and Support

27.09 Pivot Speed
  • R3 33.04
  • R2 30.94
  • R1 29.19
  • S1 25.34
  • S2 23.24
  • S3 21.49

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Parmax Pharma has an operating revenue of Rs. 13.62 Cr. on a trailing 12-month basis. An annual revenue growth of 154% is outstanding, Pre-tax margin of -8% needs improvement, NULL From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 35 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 51 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Parmax Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-14 Quarterly Results
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-30 Audited Results
2025-02-14 Quarterly Results

Parmax Pharma F&O

Parmax Pharma Shareholding Pattern

30.8%
63.08%
6.12%

About Parmax Pharma

  • NSE Symbol
  • PARMAX
  • BSE Symbol
  • 540359
  • Managing Director
  • Dr. Umang Alkesh Gosalia
  • ISIN
  • INE240T01014

Similar Stocks to Parmax Pharma

Parmax Pharma FAQs

Parmax Pharma share price is ₹27 As on 13 March, 2026 | 09:21

The Market Cap of Parmax Pharma is ₹10.4 Cr As on 13 March, 2026 | 09:21

The P/E ratio of Parmax Pharma is -2.1 As on 13 March, 2026 | 09:21

The PB ratio of Parmax Pharma is -1.7 As on 13 March, 2026 | 09:21

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23